Three-Drug Regimen for Treating Leprosy  |

Three-Drug Regimen for Treating Leprosy 


∙ The Central government has approved a new treatment regimen for leprosy, aiming to stop its transmission at the sub-national level by 2027.

Three-drug regimen

∙ The WHO has recommended this treatment regimen in 2015.

∙ It consists of three drugs — dapsone, rifampicin and clofazimine. The combination is referred to as MDT (multidrug therapy). MDT kills the pathogen and cures the patient.

∙ This regimen is known as ‘Uniform MDT’, where a single three-pack kit can be given to all leprosy patients. This measure facilitates ease of administration.

∙ The duration of treatment is six months for PB and 12 months for MB cases.


∙ Leprosy, also known as Hansen’s disease, is a chronic infectious disease caused by the slow-growing bacteria Mycobacterium leprae bacteria.

∙ It primarily affects the skin and peripheral nerves, leading to potential disabilities if left untreated.

ο Leprosy is spread through close and frequent contact with untreated individuals, most commonly via respiratory droplets from the nose and mouth.

ο Early symptoms often involve pale, painless patches on the skin that can lose sensation.

ο Leprosy can be diagnosed through skin smear tests, nerve function tests, and biopsies.

0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments

You cannot copy content of this page

Would love your thoughts, please comment.x
Scroll to Top